Related Experiment Video
Updated: Jul 16, 2025
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Pediatric Antiphospholipid Syndrome Presenting as a Massive Stroke: A Case Report
1Radiology, Salmaniya Medical Complex, Manama, BHR.
Insights
A rare pediatric stroke in a two-year-old was diagnosed as antiphospholipid syndrome. Early diagnosis and tailored anticoagulation therapy led to significant neurological improvement.
Area of Science:
- Pediatric Neurology
- Autoimmune Disorders
- Vascular Medicine
Background:
- Pediatric strokes are uncommon but severe neurological events.
- Antiphospholipid syndrome (APS) is an autoimmune condition increasing clotting risk.
- APS can manifest as arterial or venous thrombotic events.
Abstract:
Pediatric strokes are infrequent yet impactful occurrences with distinct challenges due to their unique pathophysiology and diagnostic complexities. Antiphospholipid syndrome, an autoimmune disorder characterized by antiphospholipid antibodies, can lead to prothrombotic states causing vascular occlusions. Here, we present the case of a previously healthy two-year-old girl who presented with sudden right-sided hemiparesis and altered consciousness. Comprehensive assessments and evaluations revealed a diagnosis of a massive left middle cerebral artery ischemic stroke secondary to antiphospholipid syndrome. The patient received intensive care, antiplatelet therapy, and supportive measures. Gradual improvement in neurological status and motor skills was observed during hospitalization, and the patient underwent comprehensive rehabilitation. This case emphasizes the importance of vigilance, thorough diagnostic evaluation, and tailored treatment strategies. Anticoagulation therapy plays a pivotal role, necessitating a delicate balance between thrombosis prevention and bleeding risk. The significance of multidisciplinary approaches and specialized care for pediatric stroke cases is underscored.
